Mosaic ImmunoEngineering Inc.
CPMV · OTC
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | – | $7,163 | $6,847 | $2,600 |
| - Cash | $115 | $221 | $226 | $353 |
| + Debt | $1,393 | $1,228 | $735 | $0 |
| Enterprise Value | – | $8,171 | $7,356 | $2,248 |
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | – | – | – | – |
| EBITDA | -$838 | -$2,284 | -$3,501 | – |
| % Margin | – | – | – | – |
| Net Income | -$922 | -$2,381 | -$3,684 | – |
| % Margin | – | – | – | – |
| EPS Diluted | -0.13 | -0.33 | -0.55 | – |
| % Growth | 60.6% | 40% | – | – |
| Operating Cash Flow | -$241 | -$690 | -$679 | – |
| Capital Expenditures | $0 | $0 | $0 | – |
| Free Cash Flow | -$241 | -$690 | -$679 | – |